However, other authors have described that BDNF downregulates KCC2 after injury [39,40,41,42] and mediates the decrease in KCC2 observed in neurological diseases, such as epilepsy, neuropathic pain, and spasticity [15,43,44,45]. The gene discussed is SLC12A5; the disease is nervous system disorder.